Target determination for transcranial magnetic stimulation in patients with a pharmacotherapy-resistant depressive episode based on the individual parameters of resting-state functional magnetic resonance imaging (a pilot blind controlled trial)

Target determination for transcranial magnetic stimulation in patients with a pharmacotherapy-resistant depressive episode based on the individual parameters of resting-state functional magnetic resonance imaging (a pilot blind controlled trial)

High-frequency repetitive transcranial magnetic stimulation (rTMS) is approved by the Food and Drug Administration (FDA) for the treatment of pharmacotherapy-resistant depressive disorders (DD). Individual target determination for stimulation can be one of the approaches that can increase the effici...

Full description

Bibliographic Details
Main Authors: A. G. Poydasheva, D. O. Sinitsyn, I. S. Bakulin, N. A. Suponeva, N. V. Maslennikov, E. E. Tsukarzi, S. N. Mosolov, M. A. Piradov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2019-12-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
repetitive transcranial magnetic stimulation
depression
resting-state functional magnetic resonance imaging
functional connectivity
Online Access:https://nnp.ima-press.net/nnp/article/view/1208

Internet

https://nnp.ima-press.net/nnp/article/view/1208

Similar Items